Gerber, Hans-Peter
Genentech · Seagen (United States)
4 papers on CoChatORCID 0000-0002-0741-9328
Most cited papers
- Verified
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine
Angiogenesis and VEGF in CancerLymphatic System and Diseases
Cited by 9,591
- Verified
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery
Angiogenesis and VEGF in CancerMonoclonal and Polyclonal Antibodies Research
Cited by 2,625
- Verified
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology
Angiogenesis and VEGF in CancerImmune cells in cancer
Cited by 849
- Verified
Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes
Gerber, H.-P., Condorelli, F., Park, J., & Ferrara, N. (1997) · Journal of Biological Chemistry
Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism
Cited by 794
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free